Is JAMA a Good Journal? What Physicians and Researchers Need to Know

JAMA desk-rejects most research manuscripts within 48 hours. That's not a typo. The editors read the title, Key Points, structured abstract, and sometimes the first figure, and they know whether the paper belongs here.

What survives the 2-day screen:

• Research that changes what a general internist does for patients, not "might eventually influence" but "should change practice now"
• Multi-center studies with adequate power (single-center studies are almost never accepted unless the condition is extraordinarily rare)
• Clinical significance, not just statistical significance, effect sizes and absolute risk reductions that are large enough to matter to patients

What gets desk-rejected in 2 days:

• Subspecialty research that only cardiologists, only oncologists, or only dermatologists would read. This is the #1 desk rejection reason. These papers belong in JAMA Network specialty journals, which are excellent journals, not consolation prizes
• Studies reporting p-values without clinically meaningful effect sizes. JAMA pioneered the move away from p-value fixation. A treatment that produces a 0.2% absolute risk reduction will not impress editors regardless of the p-value
• Manuscripts missing Key Points, structured abstract, or EQUATOR-compliant reporting. These are format requirements, but missing them signals the author hasn't read the instructions, and editors notice

1. The editorial rewrite. JAMA edits accepted papers more aggressively than any other major journal. The version that publishes will be substantially shorter, cleaner, and more accessible than what you submitted. This isn't optional, it's part of JAMA's brand. Don't fight the editing process. The rewritten version will be more readable and more cited by guideline committees.

2. The statistical review team. Every paper that passes desk review gets an independent statistical evaluation. JAMA's statisticians examine sample size justification, analysis appropriateness, missing data handling, and whether conclusions match data. This is co-equal with the clinical review, statistical problems caught here are included in the decision letter.

3. The "Importance" line. JAMA's structured abstract opens with "Importance:", a 1-2 sentence statement of why this question matters. Editors read it before anything else. If this line is generic ("hypertension is a leading cause of cardiovascular disease"), the editor already knows the paper isn't framed for JAMA. If it identifies a specific evidence gap that matters to practicing physicians, the next 30 seconds of the editor's attention are earned.

The single most common reason strong papers get desk-rejected from JAMA: the paper is excellent specialty research submitted to a general medical journal. A beautifully designed cardiology trial that only cardiologists would read about gets rejected not because the science is weak, but because the audience is narrow.

Authors make this mistake because they see JAMA's IF (55.0) and think "my paper is good enough." But JAMA doesn't ask "is this good enough?" It asks "do 300,000 physicians across all specialties need to know about this?" If the answer is "only cardiologists need to know," JAMA Cardiology is the right target, and it's a genuinely good journal (IF 14.8).

The test: read your abstract to a physician in a completely different specialty. If they care about the result without you explaining why it matters, the paper might be JAMA-ready. If you have to explain why it's important for medicine broadly, it's a specialty journal paper.